ClinicalTrials.gg

Program

carboxymethylcellulose

Also written as “Carboxymethylcellulose and Glycerin based artificial tear”, “Optive” and “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”.

Its studies are mostly in Dry Eye Syndromes · Keratoconjunctivitis Sicca, led by 3 companies.

Furthest: phase 4, since Jul 10, 200910 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AbbVie70 open or runningphase 4since Jul 10, 2009Oct 21, 2005none ahead
Innovative Medical20 open or runningphase 4since Nov 9, 2006Nov 9, 2006none ahead
Andover Research Eye Institute11 open or runningphase 4since Jun 24, 2026Jun 24, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 21, 2005First study: phase 3 study in Dry Eye SyndromesNew to AbbVieAbbVie · NCT00243711 · 286 enrolled · United States
  2. Nov 9, 2006Innovative Medical's first study: phase 4 study in Dry Eye SyndromesNew to Innovative MedicalInnovative Medical · NCT00399230 · United States
  3. May 2, 2007Phase 4 study in Dry Eye SyndromesInnovative Medical · NCT00469157 · 92 enrolled · United States
  4. Aug 8, 2007No phase study in Dry Eye SyndromesAbbVie · NCT00514852 · 316 enrolled · United States
  5. Oct 12, 2007No phase study in Dry Eye SyndromesAbbVie · NCT00544713 · 228 enrolled · United States
  6. Jul 10, 2009Phase 4 study in Dry Eye SyndromesAbbVie · NCT00938704 · 71 enrolled · Germany
  7. Sep 29, 2009Phase 4 study in Dry Eye SyndromesAbbVie · NCT00987727 · 82 enrolled · France
  8. Jan 6, 2014Phase 4 study in Dry Eye SyndromesAbbVie · NCT02028754 · 180 enrolled · China
  9. Apr 16, 2014Phase 4 study in Dry Eye SyndromesAbbVie · NCT02117687 · 80 enrolled · France, United Kingdom
  10. Jun 24, 2026Andover Research Eye Institute's first study: phase 4 study in Dry Eye SyndromesNew to Andover Research Eye InstituteAndover Research Eye Institute · NCT07676084 · 60 planned · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 10 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07676084Dry Eye Syndromes · United States4RecruitingAndover Research Eye InstituteOct 202660
NCT02117687Dry Eye Syndromes · France, United Kingdom4CompletedAbbVieJan 27, 201580
NCT02028754Dry Eye Syndromes · China4CompletedAbbVieMay 2013180
NCT00987727Dry Eye Syndromes · France4CompletedAbbVieJul 201082
NCT00938704Dry Eye Syndromes · Germany4CompletedAbbVieJun 200971
NCT00544713Dry Eye Syndromes · United States–CompletedAbbVieJun 2008228
NCT00514852Dry Eye Syndromes · United States–CompletedAbbVieJan 2008316
NCT00469157Dry Eye Syndromes · United States4CompletedInnovative MedicalApr 200892
NCT00399230Dry Eye Syndromes · United States4CompletedInnovative Medical
NCT00243711Dry Eye Syndromes · United States3CompletedAbbVieApr 2006286

How it is read

Names in the registry

  • “Carboxymethylcellulose and Glycerin based artificial tear”, 2 entries
  • “Optive”, 2 entries
  • “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”, 1 entry
  • “carboxymethylcellulose 0.5%/glycerin 0.9%”, 1 entry
  • “Sodium Carboxymethylcellulose”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.